TSO and MS: Phase 1 Clincal Trial Complete

The Phase 1 clinical trial of TSO for treatment of Multiple Sclerosis, conducted by Dr.Fleming at the University of Wisconsin School of Medicine and Public Health, is now complete. No adverse effects in the 5 patients, and a reduction of MRI-measured brain leasions in all 5. The abstract is available here


There are currently no comments for this post

You must have an account in order to post comments

Login | Register | Forget your password?